- Previous Close
0.0000 - Open
0.0450 - Bid 0.0450 x --
- Ask 0.1000 x --
- Day's Range
0.0450 - 0.0450 - 52 Week Range
0.0005 - 0.0780 - Volume
10,000 - Avg. Volume
2,163 - Market Cap (intraday)
7.27M - Beta (5Y Monthly) 0.30
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products in the province of British Columbia, Canada, and the state of Utah. It develops barium, iodine-based APIs, and imaging contrast agents for medical radiology. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.
voyageurpharmaceuticals.ca--
Full Time Employees
November 30
Fiscal Year Ends
Sector
Recent News: VYYRF
View MorePerformance Overview: VYYRF
Trailing total returns as of 12/16/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VYYRF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VYYRF
View MoreValuation Measures
Market Cap
7.27M
Enterprise Value
7.30M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.44
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-37.08%
Return on Equity (ttm)
-115.50%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-1.53M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
6.54k
Total Debt/Equity (mrq)
4.23%
Levered Free Cash Flow (ttm)
274k